Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07314255) titled 'The Role of Trop2 in Radioactive Iodine-131 Therapy Sensitivity in Papillary Thyroid Carcinoma' on Dec. 18, 2025.

Study Type: Observational [Patient Registry]

Primary Sponsor: Jiangxi Provincial Cancer Hospital

Condition: PTC I-131 Trop2

Intervention: Radiation: radioiodine-131 therapy

Recruitment Status: Not recruiting

Date of First Enrollment: December 18, 2025

Target Sample Size: 60

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07314255

Published by HT Digital Content Services with permission from Health Daily Digest....